Led by Dr. Mark Kimmins, the MAB will Help Guide the Development of the Company’s Mental Health Platform
Ryan Allway August 23rd, 2021 Psychedelics, Top News VANCOUVER, British Columbia, Aug. 23, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0) , a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased... Read more
Enveric Biosciences CEO, David Johnson, Issues Letter to Shareholders
Ryan Allway August 18th, 2021 Psychedelics, Top News NAPLES, Fla., Aug. 18, 2021 /PRNewswire/ — Enveric Biosciences (NASDAQ: ENVB) (“Enveric” or the “Company”), a patient-first biotechnology company developing novel therapeutic drugs to improve the quality of life for cancer patients, Chief Executive Officer, David Johnson, today is issuing an open letter to shareholders. Dear Fellow Shareholders: As... Read more
CEO Presenting on the Emerging Growth Conference on August 18. Register Now
MIAMI, Aug. 17, 2021 (GLOBE NEWSWIRE) — EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 14 th Emerging Growth Conference. The Conference identifies companies in a wide range of growth sectors,... Read more
Cannabix Technologies Granted U.S. Patent for FAIMS molecular analysis device
VANCOUVER, British Columbia, Aug. 17, 2021 (GLOBE NEWSWIRE) — Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) (the “Company” or “Cannabix”) developer of the Cannabix Marijuana Breathalyzer devices for law enforcement and the workplace, is pleased to report that the United States Patent and Trademark Office (USPTO) has granted patent No.... Read more
Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) announces its human-machine hybrid digital “mind”
Ryan Allway August 10th, 2021 Psychedelics, Top News Calgary, Alberta – TheNewswire -August 10, 2021 – (CNSX:MXT.CN) (OTC:MSTTE) “Computers are fast, accurate and stupid. Humans are slow, inaccurate and brilliant. Together they are powerful beyond imagination” – Albert Einstein The Corporation reports that it’s contracted medical professionals (see bios below) have begun generating a series... Read more
FinCanna Portfolio Company, QVI Inc., Signs Strategic Agreement with Sense Distribution to Expand Retail Reach for Brand Clients Throughout California
Ryan Allway August 5th, 2021 News, Top News VANCOUVER, BC / ACCESSWIRE / August 4, 2021 / FinCanna Capital Corp. (“FinCanna“) (CSE:CALI) (OTCQB:FNNZF) a royalty company for the U.S. licensed cannabis industry, is pleased to announce that its portfolio company, QVI Inc., a cannabis-infused product manufacturer located in Sonoma County, California,... Read more
Medxtractor Corp. (“MedX” or the “Corporation”) (CSE: MXT, OTC:MXTTF) announces a Business Refocus
Ryan Allway July 27th, 2021 Psychedelics, Top News Calgary, Alberta –TheNewswire – July 27, 2021 – Medxtractor (“MedX” or the “Corporation”) (CSE:MXT), (CNSX:MXT.CN),(OTC:MXTTF) reports its plan to refocus to proprietary health-related databases, machine-learning analysis and associated applications. The planned changes are generally as follows: Continuing development of the proprietary health-related Reference Database (“RD”) and... Read more
Silo Pharma Awarded Notice of Allowance from United States Patent and Trademark Office for Homing Peptide Patent
Ryan Allway July 27th, 2021 Psychedelics, Top News Central Nervous System Homing Peptide under development to deliver Psychedelics including Psilocybin Englewood Cliffs NJ, July 27, 2021 (GLOBE NEWSWIRE) — Silo Pharma, Inc. (OTCQB:SILO), a development-stage biopharmaceutical company focused on the use of psychedelics as a therapeutic, today announcedthat the United States... Read more
Ketamine One’s IRP Clinic Using Innovative NeuroCatch Platform to Measure Brain Function in Injured Veterans The NeuroCatch Platform is a 6-Minute Brain Function Assessment System Licensed by Health Canada as a Class II Medical Device
Ryan Allway July 22nd, 2021 Psychedelics, Top News VANCOUVER, British Columbia, July 22, 2021 (GLOBE NEWSWIRE) — KetamineOne Capital Limited (“Ketamine One” or the “Company”) (NEO: MEDI) (OTC: KONEF) (Frankfurt: MY0), a company focused on consolidating medical clinics and becoming a North American leader in mental health treatments, is pleased... Read more
Hempsana Signs Processing Agreement With New Leaf Canada
Ryan Allway July 21st, 2021 News, Top News Hempsana Holdings Ltd. (the “ Company ” or “ Hempsana ”) is pleased to announce the Company has signed a processing agreement with New Leaf Canada Inc. ( “New Leaf” ) to process 2,000kg of hemp to produce full spectrum CBD crude for revenue of up to... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )